BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32547936)

  • 1. Functional Landscape of Dysregulated MicroRNAs in Oral Squamous Cell Carcinoma: Clinical Implications.
    Ghosh RD; Pattatheyil A; Roychoudhury S
    Front Oncol; 2020; 10():619. PubMed ID: 32547936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
    Yap T; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; Seers C; McCullough M
    Cancer Prev Res (Phila); 2018 Aug; 11(8):491-502. PubMed ID: 29764807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA expression profiles in oral squamous cell carcinoma.
    Soga D; Yoshiba S; Shiogama S; Miyazaki H; Kondo S; Shintani S
    Oncol Rep; 2013 Aug; 30(2):579-83. PubMed ID: 23708842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated miRNA-mRNA spatial signature for oral squamous cell carcinoma: a prospective profiling study of Narrow Band Imaging guided resection.
    Farah CS; Fox SA; Dalley AJ
    Sci Rep; 2018 Jan; 8(1):823. PubMed ID: 29339786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer.
    Chawla JP; Iyer N; Soodan KS; Sharma A; Khurana SK; Priyadarshni P
    Oral Oncol; 2015 Aug; 51(8):731-7. PubMed ID: 26093389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
    Shi J; Bao X; Liu Z; Zhang Z; Chen W; Xu Q
    Theranostics; 2019; 9(4):920-931. PubMed ID: 30867806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
    Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
    Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy: miRNA as a potential biomarker in oral cancer.
    Mazumder S; Datta S; Ray JG; Chaudhuri K; Chatterjee R
    Cancer Epidemiol; 2019 Feb; 58():137-145. PubMed ID: 30579238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.
    Shi LJ; Zhang CY; Zhou ZT; Ma JY; Liu Y; Bao ZX; Jiang WW
    Head Neck; 2015 Jul; 37(7):970-6. PubMed ID: 24692283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma.
    Chang CC; Yang YJ; Li YJ; Chen ST; Lin BR; Wu TS; Lin SK; Kuo MY; Tan CT
    Oral Oncol; 2013 Sep; 49(9):923-931. PubMed ID: 23602254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: small molecules with a potentially role in oral squamous cell carcinoma.
    Gomes CC; de Sousa SF; Gomez RS
    Curr Pharm Des; 2013; 19(7):1285-91. PubMed ID: 23092348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.
    Ganci F; Sacconi A; Manciocco V; Sperduti I; Battaglia P; Covello R; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
    Head Neck; 2016 Apr; 38 Suppl 1():E189-97. PubMed ID: 25532855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
    J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA genetic variants: As potential diagnostic biomarkers for oral cancer.
    Tandon D; Dewangan J; Srivastava S; Garg VK; Rath SK
    Pathol Res Pract; 2018 Feb; 214(2):281-289. PubMed ID: 29103762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma.
    Thomas P; Preethi KA; Selvakumar SC; Ramani P; Sekar D
    J Oral Maxillofac Pathol; 2023; 27(2):364-373. PubMed ID: 37854932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three miRNAs signature for predicting the transformation of oral leukoplakia to oral squamous cell carcinoma.
    Chen H; Liu X; Jin Z; Gou C; Liang M; Cui L; Zhao X
    Am J Cancer Res; 2018; 8(8):1403-1413. PubMed ID: 30210912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNA signature and potential pathway targets in prostate cancer.
    Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.